24,760 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by MGO One Seven LLC

MGO One Seven LLC purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 24,760 shares of the pharmacy operator’s stock, valued at approximately $231,000.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Walgreens Boots Alliance by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after acquiring an additional 2,279,495 shares during the period. Invesco Ltd. grew its holdings in shares of Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after purchasing an additional 2,631,332 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Walgreens Boots Alliance by 5.2% in the fourth quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock worth $194,082,000 after purchasing an additional 1,020,587 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. Finally, Norges Bank purchased a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $58,241,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research report on Sunday. They issued a “hold” rating for the company. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Finally, Royal Bank of Canada upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $10.59.

Insiders Place Their Bets

In other news, Chairman Stefano Pessina bought 832,258 shares of Walgreens Boots Alliance stock in a transaction on Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the acquisition, the chairman now owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. The trade was a 0.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.4 %

NASDAQ WBA opened at $10.93 on Wednesday. The business’s 50-day moving average is $10.96 and its 200 day moving average is $10.24. The stock has a market capitalization of $9.45 billion, a PE ratio of -1.07, a PEG ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same quarter in the prior year, the company earned $1.20 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.